HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy.
Alexis F, Basto P, Levy-Nissenbaum E, Radovic-Moreno AF, Zhang L, Pridgen E, Wang AZ, Marein SL, Westerhof K, Molnar LK, Farokhzad OC.
Alexis F, et al.
ChemMedChem. 2008 Dec;3(12):1839-43. doi: 10.1002/cmdc.200800122.
ChemMedChem. 2008.
PMID: 19012296
Free PMC article.